Ondexxya - direct healthcare professional communication (DHPC)

andexanet alfa
DHPCHuman

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Περί

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Έγγραφα

Direct healthcare professional communication (DHPC): Ondexxya (andexanet alfa): Avoid use of andexanet prior to heparinization

English (EN) (171.93 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Key facts

Medicine name
Ondexxya
Active substance
andexanet alfa
Therapeutic area (MeSH)
Drug-Related Side Effects and Adverse Reactions
Procedure number
EMEA/H/C/004108/II/0011
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
V03AB
Dissemination date

Share this page